pyrazines has been researched along with Raynaud Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkson, L; Chartrand, S; Langleben, D | 1 |
| Seibold, JR; Wigley, FM | 1 |
| Denton, CP; Frenoux, JM; Frey, A; Hachulla, É; Herrick, AL; Le Brun, FO; Riemekasten, G; Schwarting, A | 1 |
| Denton, CP; Herrick, AL | 1 |
| Domsic, RT; Pauling, JD; Saketkoo, LA | 1 |
1 trial(s) available for pyrazines and Raynaud Disease
| Article | Year |
|---|---|
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.
Topics: Acetamides; Adult; Antihypertensive Agents; Bayes Theorem; Double-Blind Method; Female; Humans; Male; Middle Aged; Pyrazines; Raynaud Disease; Scleroderma, Systemic; Severity of Illness Index; Treatment Outcome | 2017 |
4 other study(ies) available for pyrazines and Raynaud Disease
| Article | Year |
|---|---|
Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
Topics: Acetamides; Antihypertensive Agents; Connective Tissue Diseases; Epoprostenol; Humans; Ischemia; Pyrazines; Raynaud Disease | 2021 |
Editorial: Clinical Trials in Raynaud's Phenomenon: A Spoonful of Sugar (Pill) Makes the Medicine Go Down (in Flames).
Topics: Acetamides; Adult; Humans; Pyrazines; Raynaud Disease; Scleroderma, Systemic; Sugars | 2017 |
Reply.
Topics: Acetamides; Adult; Humans; Pyrazines; Raynaud Disease; Scleroderma, Systemic | 2018 |
Patient Perceptions of the Raynaud's Condition Score Diary Provide Insight Into Its Performance in Clinical Trials of Raynaud's Phenomenon: Comment on the Article by Denton et al.
Topics: Acetamides; Adult; Humans; Pyrazines; Raynaud Disease; Scleroderma, Systemic | 2018 |